EUR 257.5
(1.9%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2.75 Billion EUR | -5.5% |
2022 | 2.91 Billion EUR | 15.16% |
2021 | 2.52 Billion EUR | 26.86% |
2020 | 1.99 Billion EUR | -11.23% |
2019 | 2.24 Billion EUR | 10.32% |
2018 | 2.03 Billion EUR | 144.47% |
2017 | 832 Million EUR | -26.04% |
2016 | 1.12 Billion EUR | 2.37% |
2015 | 1.09 Billion EUR | 9.68% |
2014 | 1 Billion EUR | 15.3% |
2013 | 869 Million EUR | 4.64% |
2012 | 830.47 Million EUR | 10.23% |
2011 | 753.41 Million EUR | 16.73% |
2010 | 645.45 Million EUR | 32.92% |
2009 | 485.6 Million EUR | 2.17% |
2008 | 475.29 Million EUR | 20.76% |
2007 | 393.59 Million EUR | 6.05% |
2006 | 371.13 Million EUR | 1.8% |
2005 | 364.55 Million EUR | 14.24% |
2004 | 319.12 Million EUR | 3.09% |
2003 | 309.56 Million EUR | -4.82% |
2002 | 325.23 Million EUR | -6.64% |
2001 | 348.38 Million EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 2.98 Billion EUR | 0.0% |
2023 Q2 | 3.04 Billion EUR | 0.0% |
2023 FY | 2.75 Billion EUR | -5.5% |
2023 Q4 | 2.75 Billion EUR | 0.0% |
2022 Q2 | 2.96 Billion EUR | 0.0% |
2022 FY | 2.91 Billion EUR | 15.16% |
2022 Q4 | 2.91 Billion EUR | 0.0% |
2021 Q2 | 2.11 Billion EUR | 0.0% |
2021 FY | 2.52 Billion EUR | 26.86% |
2021 Q4 | 2.52 Billion EUR | 0.0% |
2020 Q4 | 1.99 Billion EUR | 0.0% |
2020 FY | 1.99 Billion EUR | -11.23% |
2020 Q2 | 2.24 Billion EUR | 0.0% |
2019 FY | 2.24 Billion EUR | 10.32% |
2019 Q2 | 2.12 Billion EUR | 0.0% |
2019 Q4 | 2.24 Billion EUR | 0.0% |
2018 Q2 | 1.18 Billion EUR | 0.0% |
2018 FY | 2.03 Billion EUR | 144.47% |
2018 Q4 | 2.03 Billion EUR | 0.0% |
2017 Q4 | 832 Million EUR | 0.0% |
2017 FY | 832 Million EUR | -26.04% |
2017 Q2 | 1.12 Billion EUR | 0.0% |
2016 FY | 1.12 Billion EUR | 2.37% |
2016 Q2 | 1.12 Billion EUR | 0.0% |
2016 Q4 | 1.12 Billion EUR | 0.0% |
2015 FY | 1.09 Billion EUR | 9.68% |
2015 Q4 | 1.09 Billion EUR | 0.0% |
2015 Q2 | 1.09 Billion EUR | 0.0% |
2014 Q2 | 929 Million EUR | 0.0% |
2014 Q4 | 1 Billion EUR | 0.0% |
2014 FY | 1 Billion EUR | 15.3% |
2013 FY | 869 Million EUR | 4.64% |
2013 Q4 | 869 Million EUR | 0.0% |
2013 Q2 | 852.8 Million EUR | 0.0% |
2012 FY | 830.47 Million EUR | 10.23% |
2012 Q2 | 856.66 Million EUR | 312.61% |
2012 Q1 | 207.61 Million EUR | -72.44% |
2012 Q4 | 830.47 Million EUR | 300.0% |
2012 Q3 | 207.61 Million EUR | -75.76% |
2011 Q2 | 644.43 Million EUR | 242.14% |
2011 FY | 753.41 Million EUR | 16.73% |
2011 Q4 | 753.41 Million EUR | 300.0% |
2011 Q3 | 188.35 Million EUR | -70.77% |
2011 Q1 | 188.35 Million EUR | -70.82% |
2010 FY | 645.45 Million EUR | 32.92% |
2010 Q3 | 161.36 Million EUR | -74.22% |
2010 Q1 | 161.36 Million EUR | -66.77% |
2010 Q4 | 645.45 Million EUR | 300.0% |
2010 Q2 | 625.83 Million EUR | 287.84% |
2009 Q3 | 121.4 Million EUR | 0.0% |
2009 FY | 485.6 Million EUR | 2.17% |
2009 Q4 | 485.6 Million EUR | 300.0% |
2009 Q2 | 121.4 Million EUR | 0.0% |
2009 Q1 | 121.4 Million EUR | 2.17% |
2008 Q2 | 118.82 Million EUR | 0.0% |
2008 Q1 | 118.82 Million EUR | 20.76% |
2008 FY | 475.29 Million EUR | 20.76% |
2008 Q3 | 118.82 Million EUR | 0.0% |
2008 Q4 | 118.82 Million EUR | 0.0% |
2007 Q2 | 98.39 Million EUR | 0.0% |
2007 Q1 | 98.39 Million EUR | 6.05% |
2007 Q4 | 98.39 Million EUR | 0.0% |
2007 FY | 393.59 Million EUR | 6.05% |
2007 Q3 | 98.39 Million EUR | 0.0% |
2006 Q2 | 92.78 Million EUR | 0.0% |
2006 Q3 | 92.78 Million EUR | 0.0% |
2006 Q4 | 92.78 Million EUR | 0.0% |
2006 Q1 | 92.78 Million EUR | 1.8% |
2006 FY | 371.13 Million EUR | 1.8% |
2005 Q1 | 91.13 Million EUR | 14.24% |
2005 Q2 | 91.13 Million EUR | 0.0% |
2005 Q3 | 91.13 Million EUR | 0.0% |
2005 Q4 | 91.13 Million EUR | 0.0% |
2005 FY | 364.55 Million EUR | 14.24% |
2004 FY | 319.12 Million EUR | 3.09% |
2004 Q4 | 79.78 Million EUR | 0.0% |
2004 Q3 | 79.78 Million EUR | 0.0% |
2004 Q2 | 79.78 Million EUR | 0.0% |
2004 Q1 | 79.78 Million EUR | 3.09% |
2003 Q3 | 77.39 Million EUR | 0.0% |
2003 Q1 | 77.39 Million EUR | -4.82% |
2003 Q2 | 77.39 Million EUR | 0.0% |
2003 Q4 | 77.39 Million EUR | 0.0% |
2003 FY | 309.56 Million EUR | -4.82% |
2002 FY | 325.23 Million EUR | -6.64% |
2002 Q1 | 81.3 Million EUR | 0.0% |
2002 Q2 | 81.3 Million EUR | 0.0% |
2002 Q4 | 81.3 Million EUR | 0.0% |
2002 Q3 | 81.3 Million EUR | 0.0% |
2001 FY | 348.38 Million EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Crossject Société Anonyme | 3.13 Million EUR | -87647.288% |
Safe Orthopaedics SA | 4.5 Million EUR | -60889.133% |
Spineway SA | 4.4 Million EUR | -62371.604% |
Amplitude Surgical SA | 43.3 Million EUR | -6251.039% |
Sartorius Stedim Biotech S.A. | 882.4 Million EUR | -211.65% |
bonyf N.V. | 37.33 Thousand EUR | -7366431.837% |